The clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1%. This market is segmented based on products and services, phases, therapeutic areas, and regions.
Based on products and services, the clinical trial supplies market is segmented into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the market in 2015. Globalization of clinical trials and increasing outsourcing services will drive the growth of this market segment.
Complete report of Clinical Trial Supplies Market spread across 134 Pages, Profiling 10 Companies and Supported with70 Tables and 36 Figures is now available at http://www.reportsnreports.com/reports/427439-clinical-trial-supplies-market-by-products-services-logistics-distribution-manufacturing-packaging-and-labeling-phases-phase-i-phase-ii-phase-iii-therapeutic-areas-cns-mental-disorders-cardiovascular-oncology-global-forecast-to-2020.html .
The global clinical trial supplies market consists of various products and services that are used in clinical trials. This market is driven by several factors such as globalization of clinical trial activities, increasing R&D investments and government support, rising incidences of various diseases, and increasing expansion activities by CROs. Increasing patent expiry, the development of generic drugs, and high potential growth in emerging markets are all factors that have opened an array of opportunities for the market.
Clinical Trial Supplies Market Report useful for following audience
- Clinical trial supplies CROs
- Healthcare Institutions (Hospitals and Clinics)
- Clinical Trial Supplies Service Providers
- Research Institutions
- Research and Consulting Firms
- Environment, Health, and Safety Organizations
However, factors such as longer approval times for clinical trials are hampering the growth of the global market. Based on phases, the market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of this market. Growth in this segment can be attributed to the large sample size of patients and high cost of phase III trials.
Sample Copy of this Research is Available Now
The global clinical trial supplies market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan.
The major players in this market include Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).
Click now for more Details, Quiries and Discount and Other Information on this study “Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020” research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=427439 .
Apart from comprehensive geographic and product/service analysis and market sizing, clinical trial supplies market report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market.
The above-mentioned clinical trial supplies market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding service offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the market.
On related note another research titled "Clinical Trials Imaging Market” is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting is available at http://www.reportsnreports.com/reports/425876-clinical-trials-imaging-market-by-modality-ct-mri-pet-ultrasound-echocardiography-x-rays-end-user-pharmaceutical-companies-cros-medical-device-manufacturers-product-services-software-and-region-global-forecast-to-2020.html
Explore more reports on Biotechnology athttp://www.reportsnreports.com/market-research/biotechnology/
ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013